Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Type I interferons play a key role in the development of various skin diseases.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.